All updates
All updates
today 48监管与产业动态评分1818 BioSpace精选评分4141 Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
Nature Reviews Drug Discovery精选评分7575 COPD trial wins spur broad respiratory hopes
Nature Medicine精选评分5454 Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial
STAT News评分2626 STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions
监管与产业动态精选评分5656 Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer
BioSpace评分4141 Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
中文产业新闻精选Chinese source评分4040 EADV 2026｜54周EASI-75应答率超九成！司普奇拜单抗青少年中重度AD长期数据重磅发布
中文产业新闻精选Chinese source评分6969 礼来retatrutide TRIUMPH-2三期公布顶线结果：12mg组80周减重20.8%
专家解读（YouTube）精选评分7878 CSHL Keynote, Dr. Elaine Mardis, Nationwide Children's Hospital/ Ohio State University
临床试验登记评分1515 DV Plus Toripalimab With Cetirizine and Mecobalamin Pretreatment in Patients With Locally Advanced Unresectable or Metastatic Bladder Cancer
临床试验登记评分2323 A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS
临床试验登记评分1212 SBRT for Ultra-Central NonSmall Cell Lung Cancer
临床试验登记评分1919 A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
临床试验登记评分1616 Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.
临床试验登记评分2121 Phase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell Tumors
临床试验登记评分1717 Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral Therapy
临床试验登记评分1818 A Study to Learn About the Safety of BIIB147 and Its Effects in Adults With Amyotrophic Lateral Sclerosis (ALS)
临床试验登记评分1717 A Phase II Study of Ivonescimab in Combination With GEMOX as Neoadjuvant and Conversion Therapy for Biliary Tract Cancer
临床试验登记评分1919 A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age
临床试验登记评分1515 A Phase II Study of SKB264 + SKB118 in Nsq-NSCLC After EGFR-TKI Failure
临床试验登记评分1717 Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung Cancer
临床试验登记评分2828 SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Early Breast Cancer After Pathologic Complete Response
临床试验登记评分2222 A Clinical Study to Assess Safety, Efficacy and Pharmacodynamic Profile of GNT0004 in Duchenne Muscular Dystrophy
临床试验登记评分2626 Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
临床试验登记评分2727 A Phase 1b Study of C-CAR168 in Participants With Systemic Sclerosis (SSc)
临床试验登记评分2222 CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus Erythematosus
临床试验登记评分1818 SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
NEJM评分66 Menkes Disease
监管与产业动态评分2525 Inside the study for a remedy to fight Congo's deadliest Ebola outbreak
中文产业新闻Chinese source评分2828 再生元：ALN-CIDEB siRNA启动MASLD全球三期临床
中文产业新闻精选Chinese source评分3434 礼来公布口服GLP-1RA orforglipron 3期ACHIEVE-4试验详细结果
文献与产业新闻精选评分4343 At-home subcutaneous atezolizumab for non-small cell lung cancer: a prospective, single-arm phase II feasibility study
中文产业新闻Chinese source评分3434 降低46%肝病风险！再生元全球首创CIDEB靶向siRNA疗法ALN-CIDEB启动III期临床
中文产业新闻精选Chinese source评分6060 重度AS合并CAD患者TAVI PCI研究：TAVI先行非劣于PCI先行
中文产业新闻Chinese source评分2626 不只是GLP-1：礼来Eloralintide减重20.1%，胰淀素赛道正式开场
中文产业新闻Chinese source评分3030 瑞普泊肽肥胖合并PMOS Ⅱ期临床结果在EASD 2026以Late-Breaking Short Oral形式发布
监管与产业动态精选评分5050 New weight-loss injection targets fat cells: CBL-514 selectively induces apoptosis of fat cells
监管与产业动态评分1818 Pfizer touts 'dermatology momentum' as it paints fuller picture of Litfulo's vitiligo potential - Fierce Pharma
监管与产业动态评分1111 Signal or noise? > Scientists "edited" a gene and halved "bad" cholesterol – the effect has lasted for a year already - Українські Національні Новини (УНН) >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #biotech #competitivemarketing #pharmaceutical #pharma